J Cancer 2011; 2:20-25. doi:10.7150/jca.2.20 This volume

Case Report

Complications of Methylene Blue Dye in Breast Surgery: Case Reports and Review of the Literature

FJ Reyes1, MB Noelck2, C Valentino3, L Grasso-LeBeau3, JE Lang1

1. Department of General Surgery, Division of Surgical Oncology, University of Arizona, Tucson, AZ 85724, USA
2. University of Arizona College of Medicine University of Arizona, Tucson, AZ 85724, USA
3. University of Arizona Department of Pathology, Tucson, AZ 85724, USA

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Reyes FJ, Noelck MB, Valentino C, Grasso-LeBeau L, Lang JE. Complications of Methylene Blue Dye in Breast Surgery: Case Reports and Review of the Literature. J Cancer 2011; 2:20-25. doi:10.7150/jca.2.20. Available from https://www.jcancer.org/v02p0020.htm

File import instruction


Introduction: Methylene blue dye has been used worldwide successfully with few complications in breast surgery. We present two different complications involving methylene blue: 1) skin and parenchymal necrosis when dye was injected in a subdermal fashion and 2) Mycoplasma infection caused by contaminated methylene blue in breast reduction surgery.

Methods: We present two cases seen at the University of Arizona during 2008 and referred to a breast surgeon for management. We evaluated and managed complications of methylene blue dye injected by 2 referring surgeons for different indications. A review of the literature was performed.

Results: The first case is a 67 year old female diagnosed with infiltrating ductal carcinoma of the left breast for which she was treated by her initial surgeon with left segmental mastectomy and sentinel node biopsy. The operating surgeon injected methylene blue in a subareolar subdermal fashion (distant from the primary tumor); unfortunately the patient suffered skin and breast necrosis requiring multiple surgical debridements and finally achieving delayed primary closure. The second case is a 45 year old female with infiltrating lobular carcinoma with a history of Mycoplasma infection secondary to methylene blue injected for breast reduction surgery. She required multiple debridements and had granulomas masquerading as cancer on MRI that confounded her extent of disease.

Conclusions: The use of methylene blue dye in breast surgery is not without risk. In both cases methylene blue was responsible for complications requiring surgical debridement for local wound problems. In each case severe necrosis and infection were present. Methylene blue may cause not only significant morbidity, but may also produce cosmetically unsatisfactory results.

Keywords: Methylene blue, blue dye, complications, breast, surgery, adverse reactions, sentinel node